Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/PRO_140> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- PRO_140 abstract "PRO 140 is a humanized monoclonal antibody targeted against the CCR5 receptor found on T lymphocytes of the human immune system. It is being investigated as a potential therapy in the treatment of HIV infection. The United States Food and Drug Administration has designated PRO 140 for fast-track approval. In February 2008, the drug entered Phase 2 clinical trials and a phase 3 trial was begun in 2015.".
- PRO_140 wikiPageExternalLink download.cfm?companyid=PGNX&fileid=69481&filekey=f1b9747c-0555-439c-a53e-ec81cf8552eb&filename=PRO140_03.wmv.
- PRO_140 wikiPageID "14929103".
- PRO_140 wikiPageLength "7068".
- PRO_140 wikiPageOutDegree "21".
- PRO_140 wikiPageRevisionID "691442016".
- PRO_140 wikiPageWikiLink Allosteric_regulation.
- PRO_140 wikiPageWikiLink CCR5.
- PRO_140 wikiPageWikiLink CCR5_receptor_antagonist.
- PRO_140 wikiPageWikiLink Category:Entry_inhibitors.
- PRO_140 wikiPageWikiLink Category:Unnamed_monoclonal_antibodies.
- PRO_140 wikiPageWikiLink Clinical_trial.
- PRO_140 wikiPageWikiLink Common_logarithm.
- PRO_140 wikiPageWikiLink Cytodyn_Inc..
- PRO_140 wikiPageWikiLink Entry_inhibitor.
- PRO_140 wikiPageWikiLink FDA_Fast_Track_Development_Program.
- PRO_140 wikiPageWikiLink Food_and_Drug_Administration.
- PRO_140 wikiPageWikiLink AIDS.
- PRO_140 wikiPageWikiLink Humanized_antibody.
- PRO_140 wikiPageWikiLink Immune_system.
- PRO_140 wikiPageWikiLink AIDS.
- PRO_140 wikiPageWikiLink Monoclonal_antibody.
- PRO_140 wikiPageWikiLink T_cell.
- PRO_140 wikiPageWikiLinkText "PRO 140".
- PRO_140 atcPrefix "none".
- PRO_140 chemspiderid "none".
- PRO_140 legalStatus "investigational".
- PRO_140 niaidChemdb "88103".
- PRO_140 source "zu".
- PRO_140 target CCR5.
- PRO_140 type "mab".
- PRO_140 verifiedrevid "477003368".
- PRO_140 wikiPageUsesTemplate Template:Cascite.
- PRO_140 wikiPageUsesTemplate Template:Chemspidercite.
- PRO_140 wikiPageUsesTemplate Template:Drugbankcite.
- PRO_140 wikiPageUsesTemplate Template:HIVpharm.
- PRO_140 wikiPageUsesTemplate Template:Infobox_drug.
- PRO_140 wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- PRO_140 wikiPageUsesTemplate Template:Reflist.
- PRO_140 subject Category:Entry_inhibitors.
- PRO_140 subject Category:Unnamed_monoclonal_antibodies.
- PRO_140 hypernym Antibody.
- PRO_140 type ChemicalSubstance.
- PRO_140 type Drug.
- PRO_140 type Antibody.
- PRO_140 type Chemical.
- PRO_140 type Drug.
- PRO_140 type Inhibitor.
- PRO_140 type ChemicalObject.
- PRO_140 type Thing.
- PRO_140 type Q8386.
- PRO_140 comment "PRO 140 is a humanized monoclonal antibody targeted against the CCR5 receptor found on T lymphocytes of the human immune system. It is being investigated as a potential therapy in the treatment of HIV infection. The United States Food and Drug Administration has designated PRO 140 for fast-track approval. In February 2008, the drug entered Phase 2 clinical trials and a phase 3 trial was begun in 2015.".
- PRO_140 label "PRO 140".
- PRO_140 sameAs Q7120418.
- PRO_140 sameAs PRO_140.
- PRO_140 sameAs m.03h1_t9.
- PRO_140 sameAs Q7120418.
- PRO_140 wasDerivedFrom PRO_140?oldid=691442016.
- PRO_140 isPrimaryTopicOf PRO_140.